Revicki, D A <br/><br/>
Cost effectiveness of the newer atypical antipsychotics: a review of the pharmacoeconomic research evidence.  [electronic resource] 

 -  Current opinion in investigational drugs (London, England : 2000)  Jan 2001 
 - 110-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1472-4472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antipsychotic Agents--economics<br/>Benzodiazepines<br/>Clozapine--therapeutic use<br/>Cost-Benefit Analysis<br/>Dibenzothiazepines--therapeutic use<br/>Health Care Costs<br/>Humans<br/>Imidazoles--therapeutic use<br/>Indoles--therapeutic use<br/>Olanzapine<br/>Pirenzepine--analogs & derivatives<br/>Quetiapine Fumarate<br/>Randomized Controlled Trials as Topic<br/>Risperidone--therapeutic use